Clinical Trial Update: Home Transfusion for HEME [NA]

View source ↗

Summary

A completed clinical trial update from the Dana-Farber Cancer Institute regarding home transfusion for hematologic malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Hematologic Malignancy | NA | Status: COMPLETED